We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, March 7th:
La-Z-Boy Incorporated (LZB - Free Report) : This furniture products and accessories manufacturer has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 3.3% over the last 60 days.
Genocea Biosciences, Inc. : This biopharmaceutical company has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 40.4% over the last 60 days.
KalVista Pharmaceuticals, Inc. (KALV - Free Report) : This pharmaceutical company has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 7.3% over the last 60 days.
KalVista Pharmaceuticals, Inc. Price and Consensus
Ophthotech Corporation : This biopharmaceutical company has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 5.5% over the last 60 days.
Is Your Investment Advisor Fumbling Your Financial Future?
See how you can more effectively safeguard your retirement with a new Special Report, “4 Warning Signs Your Investment Advisor Might Be Sabotaging Your Financial Future.”
Image: Bigstock
Top Ranked Momentum Stocks to Buy for March 7th
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, March 7th:
La-Z-Boy Incorporated (LZB - Free Report) : This furniture products and accessories manufacturer has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 3.3% over the last 60 days.
La-Z-Boy Incorporated Price and Consensus
La-Z-Boy Incorporated price-consensus-chart | La-Z-Boy Incorporated Quote
La-Z-Boy’s shares gained 14.1% over the last one month against the S&P 500’s rise of 2.4%. The company possesses a Momentum Score of B.
La-Z-Boy Incorporated Price
La-Z-Boy Incorporated price | La-Z-Boy Incorporated Quote
Genocea Biosciences, Inc. : This biopharmaceutical company has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 40.4% over the last 60 days.
Genocea Biosciences, Inc. Price and Consensus
Genocea Biosciences, Inc. price-consensus-chart | Genocea Biosciences, Inc. Quote
Genocea Biosciences’ shares gained 44.4% over the last one month. The company possesses a Momentum Score of A.
Genocea Biosciences, Inc. Price
Genocea Biosciences, Inc. price | Genocea Biosciences, Inc. Quote
KalVista Pharmaceuticals, Inc. (KALV - Free Report) : This pharmaceutical company has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 7.3% over the last 60 days.
KalVista Pharmaceuticals, Inc. Price and Consensus
KalVista Pharmaceuticals, Inc. price-consensus-chart | KalVista Pharmaceuticals, Inc. Quote
KalVista Pharmaceuticals’ shares gained 16.3% over the last one month. The company possesses a Momentum Score of A.
KalVista Pharmaceuticals, Inc. Price
KalVista Pharmaceuticals, Inc. price | KalVista Pharmaceuticals, Inc. Quote
Ophthotech Corporation : This biopharmaceutical company has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 5.5% over the last 60 days.
Ophthotech Corporation Price and Consensus
Ophthotech Corporation price-consensus-chart | Ophthotech Corporation Quote
Ophthotech’s shares gained 14.4% over the last one month. The company possesses a Momentum Score of B.
Ophthotech Corporation Price
Ophthotech Corporation price | Ophthotech Corporation Quote
See the full list of top ranked stocks here.
Learn more about the Momentum score and how it is calculated here.
Is Your Investment Advisor Fumbling Your Financial Future?
See how you can more effectively safeguard your retirement with a new Special Report, “4 Warning Signs Your Investment Advisor Might Be Sabotaging Your Financial Future.”
Click to get it free >>